Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Effects of Buprenorphine, Clonidine, and Dexamethasone on Pain Management After Shoulder Surgery

Official title: Effects of a Triple Adjuvant Combination of Buprenorphine, Clonidine, and Dexamethasone on Duration of Brachial Plexus Blocks for Upper Extremity Surgery, a Prospective, Randomized Clinical Trial

Run by Loyola University · NCT05824832 · Data updated 2026-11-12

This study is testing if adding buprenorphine, clonidine, and dexamethasone to a common pain relief method can help people manage pain better after shoulder surgery.

More Pain, Postoperative trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorLoyola University
Academic / other
Locations1 site (Maywood, Illinois)
StatusRecruiting
StartedFebruary 28, 2023
Main results expectedJune 30, 2026
Study endsJune 30, 2026
Registry record updatedMarch 7, 2025
Trial IDNCT05824832 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are scheduled for shoulder arthroscopy and are willing to participate.

Probably not a fit

Patients with severe COPD, chronic pain requiring daily opioid use, or those with contraindications to general anesthesia may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the impact of adding buprenorphine, clonidine, and dexamethasone to Interscalene brachial plexus blocks on postoperative pain management in patients undergoing shoulder arthroscopy. A total of 120 patients will be randomly assigned to receive either the enhanced block with adjuvants or the standard block alone. The primary outcome is to assess differences in morphine requirements post-surgery between the two groups. This prospective, randomized, single-blinded study seeks to determine if the addition of these medications can improve pain control.

Why it matters

Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing upper extremity surgeries.

How similar studies have gone: Previous studies have shown promising results with similar approaches in enhancing pain management after surgical procedures.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients ≥ 18 years old
* Patients undergoing shoulder arthroscopy
* Patients willing to participate and sign informed consent

Exclusion Criteria:

* Severe COPD/other contraindication to general anesthesia
* Patient with a weight of less than 60 kg
* Dementia, not alert or oriented to person, place, or time
* Chronic pain patient with daily opioid use at home.
* Patient with allergy to local anesthetics
* Patient refusal
* Total shoulder arthroplasty
* Concomitant pain in different area from operative site.
* Pregnancy
* Patient with active infection on the injection sites for the blocks
* Patients unable or willing to understand or comply with the study protocol

Where it's running

  • Loyola University Chicago
    Maywood, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Audrice Francois, MD — Loyola University Chicago
  • Study coordinator: Susan Fargo
  • Email: sfargo@luc.edu
  • Phone: 708-216-8046

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.